Matches in SemOpenAlex for { <https://semopenalex.org/work/W2585347876> ?p ?o ?g. }
Showing items 1 to 98 of
98
with 100 items per page.
- W2585347876 abstract "S-1 is a combination of tegafur [metabolized to 5-fluorouracil (5-FU)] with the modulators gimeracil (5-chloro-2,4-dihydroxypyridine) and oteracil potassium. 5-Chloro-2,4-dihydroxypyridine maintains plasma 5-FU concentrations by inhibiting dihydropyrimidine dehydrogenase, a pyrimidine catabolism enzyme that degrades 5-FU. As 50% of 5-chloro-2,4-dihydroxypyridine is excreted in urine, renal insufficiency may increase its blood level, increasing 5-FU concentrations. We investigated whether special dose modification is needed in the presence of renal insufficiency.We compared steady state pharmacokinetics of 5-FU for the initial S-1 dose and reduced doses in patients with head and neck cancer requiring dose reduction due to renal and non-renal toxicities.Chemoradiotherapy with S-1 and cisplatin was administered every 5 weeks for two courses with a radiation dose totaling 70 Gy over 33-35 fractions. Two additional courses of adjuvant chemotherapy were administered in the case of an objective response. The S-1 and/or cisplatin dose was reduced in response to renal, hematologic or other toxicities. The primary endpoint was the change in area under the plasma concentration-versus-time curve from time 0-10 hours (5-FU AUCss 0-10) between the initial and reduced S-1 doses.Although the mean 5-FU levels in patients with non-renal toxicities significantly decreased between the full and reduced dose, the full-dose and reduced-dose mean maximum 5-FU plasma concentrations at steady state (Css max) and AUCss 0-10 in patients with renal insufficiency were similar.Standard S-1 dose reduction for renal toxicity did not result in a significant decrease in 5-FU levels at steady state. A greater reduction to lower plasma 5-chloro-2,4-dihydroxypyridine may be necessary in patients with renal insufficiency." @default.
- W2585347876 created "2017-02-10" @default.
- W2585347876 creator A5011675274 @default.
- W2585347876 creator A5021136979 @default.
- W2585347876 creator A5029056892 @default.
- W2585347876 creator A5049307873 @default.
- W2585347876 creator A5055275316 @default.
- W2585347876 creator A5068369923 @default.
- W2585347876 creator A5071919829 @default.
- W2585347876 creator A5074150160 @default.
- W2585347876 creator A5091440848 @default.
- W2585347876 date "2017-02-04" @default.
- W2585347876 modified "2023-09-22" @default.
- W2585347876 title "Pharmacokinetics of initial full and subsequent reduced doses of S-1 in patients with locally advanced head and neck cancer—effect of renal insufficiency" @default.
- W2585347876 cites W1998118760 @default.
- W2585347876 cites W2019607817 @default.
- W2585347876 cites W2066312401 @default.
- W2585347876 cites W2072802417 @default.
- W2585347876 cites W2077902459 @default.
- W2585347876 cites W2078292625 @default.
- W2585347876 cites W2086349137 @default.
- W2585347876 cites W2133349049 @default.
- W2585347876 cites W2406213538 @default.
- W2585347876 doi "https://doi.org/10.1093/jjco/hyx006" @default.
- W2585347876 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/28159957" @default.
- W2585347876 hasPublicationYear "2017" @default.
- W2585347876 type Work @default.
- W2585347876 sameAs 2585347876 @default.
- W2585347876 citedByCount "0" @default.
- W2585347876 crossrefType "journal-article" @default.
- W2585347876 hasAuthorship W2585347876A5011675274 @default.
- W2585347876 hasAuthorship W2585347876A5021136979 @default.
- W2585347876 hasAuthorship W2585347876A5029056892 @default.
- W2585347876 hasAuthorship W2585347876A5049307873 @default.
- W2585347876 hasAuthorship W2585347876A5055275316 @default.
- W2585347876 hasAuthorship W2585347876A5068369923 @default.
- W2585347876 hasAuthorship W2585347876A5071919829 @default.
- W2585347876 hasAuthorship W2585347876A5074150160 @default.
- W2585347876 hasAuthorship W2585347876A5091440848 @default.
- W2585347876 hasBestOaLocation W25853478761 @default.
- W2585347876 hasConcept C112705442 @default.
- W2585347876 hasConcept C121608353 @default.
- W2585347876 hasConcept C123321153 @default.
- W2585347876 hasConcept C126322002 @default.
- W2585347876 hasConcept C126894567 @default.
- W2585347876 hasConcept C2776530083 @default.
- W2585347876 hasConcept C2776694085 @default.
- W2585347876 hasConcept C2777299880 @default.
- W2585347876 hasConcept C2778050828 @default.
- W2585347876 hasConcept C2778239845 @default.
- W2585347876 hasConcept C2780456651 @default.
- W2585347876 hasConcept C71924100 @default.
- W2585347876 hasConcept C90924648 @default.
- W2585347876 hasConcept C98274493 @default.
- W2585347876 hasConceptScore W2585347876C112705442 @default.
- W2585347876 hasConceptScore W2585347876C121608353 @default.
- W2585347876 hasConceptScore W2585347876C123321153 @default.
- W2585347876 hasConceptScore W2585347876C126322002 @default.
- W2585347876 hasConceptScore W2585347876C126894567 @default.
- W2585347876 hasConceptScore W2585347876C2776530083 @default.
- W2585347876 hasConceptScore W2585347876C2776694085 @default.
- W2585347876 hasConceptScore W2585347876C2777299880 @default.
- W2585347876 hasConceptScore W2585347876C2778050828 @default.
- W2585347876 hasConceptScore W2585347876C2778239845 @default.
- W2585347876 hasConceptScore W2585347876C2780456651 @default.
- W2585347876 hasConceptScore W2585347876C71924100 @default.
- W2585347876 hasConceptScore W2585347876C90924648 @default.
- W2585347876 hasConceptScore W2585347876C98274493 @default.
- W2585347876 hasFunder F4320310756 @default.
- W2585347876 hasFunder F4320311653 @default.
- W2585347876 hasLocation W25853478761 @default.
- W2585347876 hasLocation W25853478762 @default.
- W2585347876 hasOpenAccess W2585347876 @default.
- W2585347876 hasPrimaryLocation W25853478761 @default.
- W2585347876 hasRelatedWork W1965311643 @default.
- W2585347876 hasRelatedWork W1970138272 @default.
- W2585347876 hasRelatedWork W1972380358 @default.
- W2585347876 hasRelatedWork W2035456243 @default.
- W2585347876 hasRelatedWork W2066333148 @default.
- W2585347876 hasRelatedWork W2069474927 @default.
- W2585347876 hasRelatedWork W2092799016 @default.
- W2585347876 hasRelatedWork W2093544927 @default.
- W2585347876 hasRelatedWork W2094313212 @default.
- W2585347876 hasRelatedWork W2111018973 @default.
- W2585347876 hasRelatedWork W2127369173 @default.
- W2585347876 hasRelatedWork W2240742849 @default.
- W2585347876 hasRelatedWork W2383166569 @default.
- W2585347876 hasRelatedWork W2416780186 @default.
- W2585347876 hasRelatedWork W2416959267 @default.
- W2585347876 hasRelatedWork W2417079461 @default.
- W2585347876 hasRelatedWork W2417932277 @default.
- W2585347876 hasRelatedWork W2426519015 @default.
- W2585347876 hasRelatedWork W2469280397 @default.
- W2585347876 hasRelatedWork W3020966999 @default.
- W2585347876 isParatext "false" @default.
- W2585347876 isRetracted "false" @default.
- W2585347876 magId "2585347876" @default.
- W2585347876 workType "article" @default.